Emerging insights into origin and pathobiology of primary central nervous system lymphoma
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 509, 121-129
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81911530169)
- National Natural Science Foundation of China (81903088)
- National Natural Science Foundation of China (81670180)
This publication has 86 references indexed in Scilit:
- Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System LymphomasClinical Cancer Research, 2012
- Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer TherapiesAdvances in Hematology, 2012
- Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of gliomaNeuro-Oncology, 2011
- Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomasNeuro-Oncology, 2011
- Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristicsClinical and Experimental Immunology, 2011
- Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent ReporterCell, 2010
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyProceedings of the National Academy of Sciences, 2010
- Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohortNeuro-Oncology, 2010
- BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphomaProceedings of the National Academy of Sciences, 2009
- Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the Eμ-myc Model and Human Diffuse Large B-Cell LymphomaCancer Research, 2008